EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Multidose transient transfection of human embryonic kidney 293 cells modulates recombinant adeno‐associated virus2/5 Rep protein expression and influences the enrichment fraction of filled capsids

Prasanna Srinivasan, Christopher T Canova, Sha Sha, Tam N T Nguyen, John Joseph, Jose Sangerman, Andrew J Maloney, Georgios Katsikis, Rui Wen Ou, Moo Sun Hong, Jaclyn Ng, Arella Yuan und 9 weitere

Biotechnology and Bioengineering · 2024-12 · 121 (12) · 3694-3714

DOI: 10.1002/bit.28828 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Bioengineering, online erschienen am 23.08.2024. Verfasst von Prasanna Srinivasan und 20 weiteren Autor:innen. Beteiligte Einrichtung: Center for Biomedical Innovation, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. Hauptthemen laut MEDLINE: Capsid, Dependovirus, Transfection. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Massachusetts Life Sciences Center, MathWorks Engineering Fellowship, U.S. Food and Drug Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recombinant adeno‐associated virus (rAAV) is a commonly used in vivo gene therapy vector because of its nonpathogenicity, long‐term transgene expression, broad tropism, and ability to transduce both dividing and nondividing cells. However, rAAV vector production via transient transfection of mammalian cells typically yields a low fraction of filled‐to‐total capsids (~1%–30% of total capsids produced). Analysis of our previously developed mechanistic model for rAAV2/5 production attributed these low fill fractions to a poorly coordinated timeline between capsid synthesis and viral DNA replication and the repression of later phase capsid formation by Rep proteins. Here, we extend the model by quantifying the expression dynamics of total Rep proteins and their influence on the key steps of rAAV2/5 production using a multiple dosing transfection of human embryonic kidney 293 (HEK293) cells. We report that the availability of preformed empty capsids and viral DNA copies per cell are not limiting to the capsid‐filling reaction. However, optimal expression of Rep proteins (12% of total capsids/cell) upstream. Our analysis suggests increased enrichment of filled capsids via regulating the expression of Rep proteins is possible but at the expense of per cell capsid titer in a triple plasmid transfection. Our study reveals an intrinsic limitation of scaling rAAV2/5 vector genome (vg) production and underscores the need for approaches that allow for regulating the expression of Rep proteins to maximize vg titer per cell upstream.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CapsidDependovirusTransfectionHumansHEK293 CellsDNA-Binding ProteinsViral ProteinsGenetic VectorsRecombinant Proteins

Stichwörter der Autor:innen

Adeno‐associated virusgene therapymechanistic modelingtransfectionvector manufacturing

Substanzen

DNA-Binding ProteinsViral Proteinsrep proteins, Adeno-associated virus 2Recombinant Proteins

Autor:innen und Institutionen

  • Center for Biomedical Innovation, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Ultragenyx Pharmaceutical Inc., Novato, Cambridge, USA.
  • BioNTech SE, Cambridge, Massachusetts, USA.
  • Amgen, Cambridge, Massachusetts, USA.
  • Anthology, Cambridge, Massachusetts, USA.

Förderung

  • Massachusetts Life Sciences Center
  • MathWorks Engineering Fellowship
  • U.S. Food and Drug Administration

Zitieren

APA

Srinivasan, P., Canova, C. T., Sha, S., Nguyen, T. N. T., Joseph, J., Sangerman, J., Maloney, A. J., Katsikis, G., Ou, R. W., Hong, M. S., Ng, J., Yuan, A., Antov, D., Song, S., Chen, W., Neufeld, C., Wolfrum, J. M., Barone, P. W., Sinskey, A. J., …, & Braatz, R. D. (2024). Multidose transient transfection of human embryonic kidney 293 cells modulates recombinant adeno‐associated virus2/5 Rep protein expression and influences the enrichment fraction of filled capsids. Biotechnology and Bioengineering, 121(12), 3694-3714. https://doi.org/10.1002/bit.28828

Vancouver

Srinivasan P, Canova CT, Sha S, Nguyen TNT, Joseph J, Sangerman J, et al. Multidose transient transfection of human embryonic kidney 293 cells modulates recombinant adeno‐associated virus2/5 Rep protein expression and influences the enrichment fraction of filled capsids. Biotechnology and Bioengineering. 2024;121(12):3694-3714. doi:10.1002/bit.28828

BibTeX
@article{Srinivasan2024,
  author = {Srinivasan, Prasanna and Canova, Christopher T and Sha, Sha and Nguyen, Tam N T and Joseph, John and Sangerman, Jose and Maloney, Andrew J and Katsikis, Georgios and Ou, Rui Wen and Hong, Moo Sun and Ng, Jaclyn and Yuan, Arella and Antov, Daniel and Song, Sally and Chen, Wenyu and Neufeld, Caleb and Wolfrum, Jacqueline M and Barone, Paul W and Sinskey, Anthony J and Springs, Stacy L and Braatz, Richard D},
  title = {Multidose transient transfection of human embryonic kidney 293 cells modulates recombinant adeno‐associated virus2/5 Rep protein expression and influences the enrichment fraction of filled capsids},
  journal = {Biotechnology and Bioengineering},
  year = {2024},
  volume = {121},
  number = {12},
  pages = {3694--3714},
  doi = {10.1002/bit.28828}
}
Kostenlos starten →